Purpose | Dosage Range | Frequency | Administration |
---|---|---|---|
General Use | 50-150 mg | 1-3x daily | Oral capsules |
Weight Loss | 100-150 mg | 1-2x daily | Oral capsules |
Research | 10-150 mg/kg/day | As per protocol | Oral/Injectable (animal studies) |
2. What is 5-Amino-1MQ?
Chemical formula: C10H11N2+
Structure: Quinoline ring with an amino group at position 5 and a methyl group at position 1
Developed as a selective NNMT inhibitor
Primarily studied for its effects on metabolism and weight loss
Not FDA-approved; currently used in research settings
Inhibits NNMT, an enzyme predominantly active in fat tissue
Increases nicotinamide adenine dinucleotide (NAD+) levels
Activates sirtuin-1 (SIRT1), also known as "the longevity gene"
Enhances cellular metabolism and energy expenditure
Promotes fat burning while preserving muscle mass
Regulates energy expenditure in fat cells
May increase NAD+ and S-adenosyl methionine (SAM) concentrations in fat cells
Promotes fat loss while preserving muscle mass
May reverse diet-induced obesity
Enhances metabolic rate and fat burning
Potential treatment for type 2 diabetes and metabolic syndrome
May improve insulin sensitivity
Could lower cholesterol levels and improve blood sugar control
Enhances aged muscle regeneration
May promote muscle growth and recovery
Potential benefits for sarcopenia (age-related muscle loss)
Shows promise in combating various cancer types
May disrupt energy supply to cancer cells
Potential to enhance effectiveness of cancer therapies
Activates SIRT1, associated with longevity
May have anti-inflammatory properties
Potential to improve overall healthspan
Typical dose: 50-150 mg per day
Often divided into 1-3 doses
Higher dose: 100-150 mg per day
Usually divided into 1-2 doses
Dose range in animal studies: 10-150 mg/kg/day
Human equivalent doses not established
No mixing required for oral capsules
For research purposes, may be reconstituted with appropriate solvents
Always follow manufacturer's instructions for handling and administration
Most common method for human use
Take capsules on an empty stomach
May be taken once daily or divided into multiple doses
Used in animal studies
Not typically used in human applications
NAD+ boosters
Other metabolic enhancers
Exercise regimens for enhanced fat loss
No significant adverse effects reported in preclinical trials
Human safety data is limited
Nausea
Headache
Increased appetite (due to increased metabolic rate)
Not approved by the FDA for human use
Legal status varies by country and jurisdiction
Often restricted to research or medical use
In the US, it's legal to possess for research purposes but not for human consumption
Always check local laws before purchasing or using 5-Amino-1MQ
Store in a cool, dry place away from direct light
Keep at room temperature (20-25°C or 68-77°F)
Protect from moisture
Keep out of reach of children
Use within the expiration date
Effects may vary, but some users report noticeable changes in energy levels and metabolism within 2-4 weeks of consistent use.
While not primarily designed for bodybuilding, its potential to preserve muscle mass during fat loss may be beneficial for body composition goals.
Long-term safety data in humans is limited. More research is needed to establish its safety profile for extended use.
5-Amino-1MQ's unique mechanism of NNMT inhibition sets it apart from many traditional weight loss supplements, potentially offering metabolic benefits beyond simple calorie reduction.
5-Amino-1MQ shows promise as a novel compound for metabolic health, weight management, and potentially anti-aging applications. The typical dosage range of 50-150 mg per day appears effective for most research applications. Its unique mechanism of NNMT inhibition offers a new approach to tackling obesity and metabolic disorders.However, its use should be approached cautiously due to limited long-term human safety data and varying legal status worldwide. As with any experimental compound, thorough research and professional consultation are essential before use. The potential
of 5-Amino-1MQ in weight management, metabolic health, and age-related conditions warrants further investigation, particularly in larger, long-term human trials.
Neelakantan H, et al. (2019). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology, 164, 165-180.
Kannt A, et al. (2018). A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Scientific Reports, 8(1), 3660.
Kraus D, et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature, 508(7495), 258-262.
Hong S, et al. (2015). Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine, 21(8), 887-894.
Ulanovskaya OA, et al. (2013). NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nature Chemical Biology, 9(5), 300-306.
Disclaimer
Peptideresearcher.com contains information about products intended for research and laboratory use only, unless otherwise explicitly stated. All content is for educational purposes and is not meant to substitute for professional medical advice. Peptideresearcher.com strives to ensure that all information presented is accurate and complies with national and international standards, but it is not guaranteed. The content provided is not intended to diagnose, treat, cure, or prevent any disease or condition.
Peptideresearcher.com does not offer medical diagnoses or prescriptions. Any product information shared is solely for research purposes and should be used by qualified professionals only. We advise all users to consult with a healthcare professional before using any peptides, supplements, or medications mentioned on this site. All opinions expressed are those of the individual authors and may not reflect the opinions of Peptideresearcher.com.
Copyright 2024 - Peptide Researcher
Your access to Peptideresearcher.com is subject to our Terms of Use